0001575872-23-001625.txt : 20231019 0001575872-23-001625.hdr.sgml : 20231019 20231019094105 ACCESSION NUMBER: 0001575872-23-001625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231012 FILED AS OF DATE: 20231019 DATE AS OF CHANGE: 20231019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verleun Noah CENTRAL INDEX KEY: 0001862713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12627 FILM NUMBER: 231333578 MAIL ADDRESS: STREET 1: 2709 SKYPARK DRIVE STREET 2: SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Clean Energy Holdings, Inc. CENTRAL INDEX KEY: 0000748790 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870407858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 BUSINESS PHONE: (310) 641-4234 MAIL ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL DISCOVERIES INC DATE OF NAME CHANGE: 19940303 FORMER COMPANY: FORMER CONFORMED NAME: WPI PHARMACEUTICAL INC DATE OF NAME CHANGE: 19930126 FORMER COMPANY: FORMER CONFORMED NAME: WESTPORT PHARMACEUTICAL INC DATE OF NAME CHANGE: 19850111 4 1 ownership.xml X0508 4 2023-10-12 0 0000748790 Global Clean Energy Holdings, Inc. GCEH 0001862713 Verleun Noah 2790 SKYPARK DRIVE, SUITE 105 TORRANCE, CA 90505 0 1 0 0 President 0 Stock Option (right to buy) 0.20 2023-10-12 4 D 0 5000000 D 2024-01-14 Common Stock 5000000 0 D Stock Option (right to buy) 0.97 2023-10-12 4 A 0 5000000 A 2029-01-14 Common Stock 5000000 5000000 D Stock Option (right to buy) 0.165 2023-10-12 4 D 0 950000 D 2024-06-20 Common Stock 950000 0 D Stock Option (right to buy) 0.97 2023-10-12 4 A 0 950000 A 2029-06-20 Common Stock 950000 950000 D Stock Option (right to buy) 0.165 2023-10-12 4 D 0 50000 D 2024-06-20 Common Stock 50000 0 D Stock Option (right to buy) 0.97 2023-10-12 4 A 0 50000 A 2029-06-20 Common Stock 50000 50000 D The reported transactions involved an amendment of outstanding options, resulting in the cancellation of the "old" options and the grant of replacement options. The options were originally granted on January 15, 2019 and June 21, 2019, respectfully, and are fully vested. The effectiveness of the amendment of the outstanding options is subject stockholder approval. /s/ Noah Verleun 2023-10-19